European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis

AB Chang, R Fortescue, K Grimwood… - European …, 2021 - Eur Respiratory Soc
There is increasing awareness of bronchiectasis in children and adolescents, a chronic
pulmonary disorder associated with poor quality of life for the child/adolescent and their …

[HTML][HTML] Use of corticosteroids in asthma and COPD patients with or without COVID-19

SS Hasan, T Capstick, STR Zaidi, CS Kow… - Respiratory …, 2020 - Elsevier
The potential detrimental effects of steroids on the immune system to fight viral infections
had always been a concern for patients on long term steroids in chronic conditions. A recent …

[HTML][HTML] Inhaled corticosteroids and the pneumonia risk in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials

H Chen, J Sun, Q Huang, Y Liu, M Yuan… - Frontiers in …, 2021 - frontiersin.org
Background: Whether all types of inhaled corticosteroids (ICSs) would increase the
pneumonia risk in patients with chronic obstructive pulmonary disease (COPD) remains …

Effects of Inhaled Corticosteroid/Long-Acting β2-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A …

FS Leitao Filho, H Takiguchi, K Akata… - American journal of …, 2021 - atsjournals.org
Rationale: Inhaled corticosteroids (ICS) are commonly prescribed with long-acting β2-
agonists (LABA) in chronic obstructive pulmonary disease (COPD). To date, the effects of …

[HTML][HTML] Phosphodiesterase-4 inhibitors for non-COPD respiratory diseases

T Kawamatawong - Frontiers in pharmacology, 2021 - frontiersin.org
Selective phosphodiesterase (PDE) inhibitors are a class of nonsteroid anti-inflammatory
drugs for treating chronic inflammatory diseases. Modulation of systemic and airway …

[HTML][HTML] Current challenges in chronic bronchial infection in patients with chronic obstructive pulmonary disease

JL Lopez-Campos, M Miravitlles… - Journal of clinical …, 2020 - mdpi.com
Currently, chronic obstructive pulmonary disease (COPD) patients and their physicians face
a number of significant clinical challenges, one of which is the high degree of uncertainty …

[HTML][HTML] Health-related quality of life and its associated factors in patients with chronic obstructive pulmonary disease

AS Jarab, W Al-Qerem, KH Alzoubi, S Abu Heshmeh… - Plos one, 2023 - journals.plos.org
Objective The present study aimed to evaluate HRQOL and to explore the factors associated
with poor HRQOL among patients with COPD. Methods In the present cross-sectional study …

[HTML][HTML] Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease

C Janson - Journal of Thoracic Disease, 2020 - ncbi.nlm.nih.gov
In chronic obstructive pulmonary disease (COPD), treatment with inhaled corticosteroids
(ICSs) in combination with long acting beta-2-agonists (LABA) or LABA/long-acting …

[HTML][HTML] The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19

F Furci, M Caminati, G Senna, S Gangemi - Clinical and Molecular Allergy, 2021 - Springer
Background The observation of patients hospitalized for coronavirus disease (COVID-19)
led us to note a lower prevalence of patients affected by chronic respiratory disease, in …

[HTML][HTML] Inhaled corticosteroids selectively alter the microbiome and host transcriptome in the small airways of patients with chronic obstructive pulmonary disease

W Yip, X Li, GJ Koelwyn, S Milne, FS Leitao Filho… - Biomedicines, 2022 - mdpi.com
Background: Patients with chronic obstructive pulmonary disease (COPD) are commonly
treated with inhaled corticosteroid/long-acting ß2-agonist combination therapy. While …